Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution. - Mishra D; Patel A; Panjwani D; Patel S; Kushwaha N; Ahlawat P; Patel V (Discover oncology, 2026)